Research advances on traditional Chinese medicine monomers and compounds intervening in ankylosing spondy-litis-related signaling pathways
- VernacularTitle:中药单体和复方干预强直性脊柱炎的相关信号通路研究进展
- Author:
Haidong ZHOU
1
;
Yaohong LU
1
;
Liangshen HU
2
;
Li GONG
2
;
Maohua LIN
1
;
Shipeng HAO
1
;
Jianbin YAN
1
;
Weihui CHEN
1
;
Shaoyong FAN
2
Author Information
1. School of Clinical Medicine，Jiangxi University of Chinese Medicine，Nanchang 330004，China
2. Dept. of Sports Medicine，Hongdu Hospital of Traditional Chinese Medicine，Jiangxi University of Chinese Medicine，Nanchang 330038，China
- Publication Type:Journal Article
- Keywords:
traditional Chinese medicine;
compound;
monomer;
ankylosing spondylitis;
signaling pathway;
immune
- From:
China Pharmacy
2025;36(3):373-378
- CountryChina
- Language:Chinese
-
Abstract:
Ankylosing spondylitis is a chronic immunoinflammatory disease that mainly affects the spine and the sacroiliac joint， the mechanism of which is closely related to signaling pathways， such as osteoprotegerin （OPG）/receptor activator of nuclear factor-κB （RANK）/RANK ligand， mitogen-activated protein kinase （MAPK）， Wnt/β-catenin （β-catenin）， phosphoinositide 3- kinase/protein kinase B/mammalian target of rapamycin （PI3K/Akt/mTOR）. Traditional Chinese medicine has the characteristics of multiple components and targets， and is widely used for the treatment of autoimmune diseases due to its low toxicity， strong specificity， and high efficacy. This review found that monomers and compounds of traditional Chinese medicine can exert anti ankylosing spondylitis effects by intervening in the aforementioned signaling pathways， regulating immune inflammatory responses， and inhibiting biological processes such as bone destruction， ectopic osteogenic differentiation， cell apoptosis， and autophagy.
